{"id":"W4292330677","doi":"10.1016/j.ajpc.2022.100372","title":"Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease","year":2022,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Resverlogix (Canada)","funders":"Kowa Company; National Institute on Handicapped Research; Roche; Silence Therapeutics; Amgen; Pfizer; AbbVie; Merck; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Mace; Type 2 Diabetes Mellitus; Acute coronary syndrome; Myocardial infarction; Cirrhosis; Placebo; Cardiology; Nonalcoholic fatty liver disease; Type 2 diabetes; Gastroenterology; Diabetes mellitus; Disease; Percutaneous coronary intervention; Fatty liver; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007671773,0.0004334594,0.001033842,0.000208408,0.0001520606,0.0003747779,0.0002363951,0.0003250765,0.0005864202],"category_scores_gemma":[0.0009364367,0.0001942004,0.0006969974,0.0001777989,0.0002188194,0.0002812929,0.0002361968,0.0008007292,0.00007399886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001738356,"about_ca_system_score_gemma":0.0002445203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005562182,"about_ca_topic_score_gemma":0.00132887,"domain_scores_codex":[0.999738,0.0001382863,0.00002328146,0.0000340667,0.00003146055,0.00003489017],"domain_scores_gemma":[0.9996093,0.0001097775,0.00009399257,0.00002390497,0.00002071041,0.0001423179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7308623,0.0105797,0.08813784,0.0005973298,0.003378555,0.0002327704,0.0001939809,0.001732497,0.04010898,0.0001877841,0.0006171394,0.1233713],"study_design_scores_gemma":[0.1392048,0.3126475,0.5329513,0.00007492965,0.0027599,0.0005005198,0.0001605594,0.004540704,0.004943354,0.000431447,0.001728475,0.00005652422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982997,0.001185977,0.00009808081,0.0000446199,0.00001956619,0.00004743919,0.00004585593,0.0000075068,0.0002514058],"genre_scores_gemma":[0.9990451,0.0003792907,0.0002087624,0.00007622508,0.00002891997,0.0000320365,0.00008573281,9.525364e-7,0.0001429557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001033842,"threshold_uncertainty_score":0.004057229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002899546858357316,"score_gpt":0.1897503837880307,"score_spread":0.1868508369296734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}